NEO
NeoGenomics Inc
19.30$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 72.4% | 26.9% | 23.4% | 24.7% | 20.5% | 41.0% | 45.4% | 36.4% | 34.8% | 35.5% | 36.4% | 27.7% | |
| 41.5% | 6.4% | 3.7% | 3.7% | 1.9% | 24.4% | 23.1% | 16.9% | 15.1% | 20.4% | 22.4% | 11.7% | |
| 41.5% | 6.4% | 3.7% | 3.7% | 1.9% | 24.4% | 30.0% | 27.6% | 25.2% | 24.7% | 23.6% | 11.7% | |
| 25.2% | 13.3% | 16.5% | 17.6% | 15.2% | 13.4% | 10.8% | 6.0% | 6.9% | 7.8% | 9.2% | 11.7% | |
| 3.2% | 1.4% | 1.9% | 2.2% | 1.7% | 2.0% | 3.0% | 1.3% | 1.4% | 1.4% | 1.6% | 2.1% | |
| 18.6% | 9.4% | 10.1% | 10.6% | 12.1% | 9.0% | 8.7% | 11.3% | 5.9% | – | – | – | |
| 3.6% | 39.8% | 43.6% | 42.8% | 39.2% | 28.0% | 21.4% | 28.2% | 30.0% | 31.1% | 31.9% | 38.6% | |
| 5.2% | 23.9% | 22.9% | 21.6% | 27.7% | 17.8% | 12.2% | 23.7% | 23.5% | 22.2% | 20.7% | 21.1% | |
| 25.5% | 35.3% | 44.6% | 40.1% | 36.5% | 28.5% | 29.8% | 40.7% | 42.6% | 44.0% | 44.9% | 38.5% | |
| 18.0% | 10.9% | 17.8% | 10.2% | 12.1% | 9.0% | 7.4% | 4.7% | 5.2% | 5.7% | 18.4% | 6.5% | |
| 4.0% | 3.8% | 9.1% | 2.6% | 4.1% | 1.9% | 0.8% | 0.5% | 0.4% | 0.3% | 12.5% | 0.4% | |
| 7.8% | 3.4% | 8.7% | 3.0% | 3.5% | 2.8% | 2.5% | 1.0% | 1.2% | 1.2% | 1.3% | 1.7% | |
| 6.5% | 14.2% | 27.3% | 26.5% | 18.4% | 12.9% | 17.0% | 28.5% | 30.8% | 32.0% | 20.8% | 25.1% | |
| 74.5% | 64.7% | 55.4% | 59.9% | 63.5% | 71.5% | 70.2% | 59.3% | 57.4% | 56.0% | 55.1% | 61.5% | |
| -23.9% | -6.0% | -15.6% | -16.7% | -10.1% | -1.6% | -0.7% | -0.8% | -9.1% | -14.7% | -19.9% | -31.9% | |
| 13.8% | 3.3% | 23.0% | 4.6% | 3.6% | 2.9% | 2.3% | 1.3% | 1.4% | 1.5% | 1.5% | 1.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.